Aripiprazole-Induced Diurnal and Nocturnal Enuresis in Down’s Syndrome

References

• Agarwal, V. (2000). Urinary incontinence with risperidone. The Journal of Clinical Psychiatry, 61, 219. doi:10.4088/JCP.v61n0312f
   PubMed Web of Science ®Google Scholar
• Ambrosini, P. J. (1984). A pharmacological paradigm for urinary incontinence and enuresis. Journal of Clinical Psychopharmacology, 4, 247–253. doi:10.1097/00004714-198410000-00003
   PubMed Web of Science ®Google Scholar
• Andersson, K. E., & Pehrson, R. (2003). CNS involvement in overactive bladder: Pathophysiology and opportunities for pharmacological intervention. Drugs, 63, 2595–2611. doi:10.2165/00003495-200363230-00003
   PubMed Web of Science ®Google Scholar
• Aronowitz, J., Safferman, A., & Lieberman, J. (1995). Management of clozapine-induced enuresis. American Journal of Psychiatry, 152, 472. doi:10.1176/ajp.152.3.472a
   PubMed Web of Science ®Google Scholar
• Blok, B., Willemsen, T., & Holstege, G. (1997). A PET study of brain control of micturition in humans. Brain, 120, 111–121. doi:10.1093/brain/120.1.111
   PubMed Web of Science ®Google Scholar
• Burstein, E. S., Ma, J., Wong, S., Gao, Y., Pham, E., Knapp, A. E., … Brann, M. R. (2005). Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: Identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist. Journal of Pharmacology and Experimental Therapeutics, 315(3), 1278–1287. doi:10.1124/jpet.105.092155
   PubMed Web of Science ®Google Scholar
• Davies, M. A., Sheffler, D. J., & Roth, B. L. (2004). Aripiprazole: A novel atypical antipsychotic drug with a uniquely robust pharmacology. CNS Drug Reviews, 10(4), 317–336. doi:10.1111/j.1527-3458.2004.tb00030.x
   PubMedGoogle Scholar
• de Carvalho Mrad, F. C., de Bessa, J., Jr, de Rezende Duarte, A. M., Vieira, A. A., Araujo, F. C., de Sá Camargo, M. L., … de Bastos Netto, J. M. (2014). Prevalence of lower urinary tract symptoms in individuals with Down syndrome. Journal of Pediatric Urology, 10(5), 844–849. doi:10.1016/j.jpurol.2014.02.011
   PubMed Web of Science ®Google Scholar
• DeLeon, A., Patel, N. C., & Crismon, M. L. (2004). Aripiprazole: A comprehensive review of its pharmacology, clinical efficacy, and tolerability. Clinical Therapeutics, 26(5), 649–666. doi:10.1016/S0149-2918(04)90066-5
   PubMed Web of Science ®Google Scholar
• Frankenburg, F. R., Kando, J. C., Centorrino, F., & Gilbert, J. M. (1996). Bladder dysfunction associated with clozapine therapy. Journal of Clinical Psychiatry, 57, 39–40.
   PubMed Web of Science ®Google Scholar
• Gunes, S. (2017). Aripiprazole-related diurnal enuresis in children: 2 cases (Aripiprazole-related enuresis). Clinical Neuropharmacology, 40(4), 175–176. doi:10.1097/WNF.0000000000000223
   PubMed Web of Science ®Google Scholar
• Harrison-Woolrych, M., Skegg, K., Ashton, J., Herbison, P., & Skegg, D. C. (2011). Nocturnal enuresis in patients taking clozapine, risperidone, olanzapine and quetiapine: Comparative cohort study. The British Journal of Psychiatry, 199, 140–144. doi:10.1192/bjp.bp.110.087478
   PubMed Web of Science ®Google Scholar
• Jordan, S., Koprivica, V., Chen, R., Tottori, K., Kikuchi, T., & Altar, C. A. (2002). The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor. European Journal of Pharmacology, 441(3), 137–140. doi:10.1016/S0014-2999(02)01532-7
   PubMed Web of Science ®Google Scholar
• Kantrowitz, J. T., Srihari, V. H., & Tek, C. (2006). Three cases of risperidone-induced enuresis. Schizophrenia Research, 84, 174–175. doi:10.1016/j.schres.2006.01.023
   PubMed Web of Science ®Google Scholar
• Karakurt, M. N., & Süren, S. (2015). Desmopressin use in the treatment of aripiprazole-induced nocturnal enuresis in a child diagnosed with autistic disorder. Journal of Child and Adolescent Psychopharmacology, 25(6), 518–519. doi:10.1089/cap.2015.0003
   PubMed Web of Science ®Google Scholar
• Kinghorn, W. A., & McEvoy, J. P. (2005, May). Aripiprazole: Pharmacology, efficacy, safety and tolerability. Expert Review on Neurotherapeutics, 5(3), 297–307. doi:10.1586/14737175.5.3.297
   PubMedGoogle Scholar
• Kitamura, A., Kondoh, T., Noguchi, M., Hatada, T., Tohbu, S., Mori, K. I., … Moriuchi, H. (2014). Assessment of lower urinary tract function in children with Down syndrome. Pediatrics International, 56(6), 902–908. doi:10.1111/ped.12367
   PubMed Web of Science ®Google Scholar
• Lawler, C. P., Prioleau, C., Lewis, M. M., Mak, C., Jiang, D., Schetz, J. A., … Mailman, R. B. (1999). Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes. Neuropsychopharmacology, 20(6), 612–627. doi:10.1016/S0893-133X(98)00099-2
   PubMed Web of Science ®Google Scholar
• Lee, M. J., & Kim, C. E. (2010). Use of aripiprazole in clozapine induced enuresis: Report of two cases. Journal of Korean Medical Science, 25(2), 333–335. doi:10.3346/jkms.2010.25.2.333
   PubMed Web of Science ®Google Scholar
• Leucht, S., Cipriani, A., Spineli, L., Mavridis, D., Orey, D., Richter, F., … Davis, J. M. (2013). Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: A multiple-treatments meta-analysis. Lancet, 14, 382(9896), 951–962. doi:10.1016/S0140-6736(13)60733-3
   Web of Science ®Google Scholar
• Niemczyk, J., von Gontard, A., Equit, M., Medoff, D., Wagner, C., & Curfs, L. (2017). Incontinence in persons with Down syndrome. Neurourology Urodynamics, 36(6), 1550–1556. doi:10.1002/nau.v36.6
   PubMed Web of Science ®Google Scholar
• Nour, S., Svarer, C., Kristensen, J. K. I., Paulson, O. B., & Law, I. (2000). Cerebral activation during micturition in normal men. Brain, 123, 781–789. doi:10.1093/brain/123.4.781
   PubMed Web of Science ®Google Scholar
• Palaniappan, P. (2015). Aripiprazole as a treatment option for clozapine-induced enuresis. Indian Journal of Pharmacology, 47(5), 574–575. doi:10.4103/0253-7613.165176
   PubMed Web of Science ®Google Scholar
• Powers, M. K., Brown, E. T., Hogan, R. M., Martin, A. D., Ortenberg, J., & Roth, C. C. (2015). Trends in toilet training and voiding habits among children with Down syndrome. Journal of Urology, 194(3), 783–787. doi:10.1016/j.juro.2015.03.114
   PubMed Web of Science ®Google Scholar
• Praharaj, S. K., & Arora, M. (2007). Amitriptyline for clozapine-induced nocturnal enuresis and sialorrhoea. The British Journal of Clinical Pharmacology, 63, 128–129. doi:10.1111/bcp.2007.63.issue-1
   PubMed Web of Science ®Google Scholar
• Shapiro, D. A., Renock, S., Arrington, E., Chiodo, L. A., Liu, L. X., Sibley, D. R., … Mailman, R. (2003). Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology, 28(8), 1400–1411. doi:10.1038/sj.npp.1300203
   PubMed Web of Science ®Google Scholar
• Sugaya, K., Nishijima, S., Miyazato, M., & Ogawa, Y. (2005). Central nervous control of micturition and urine storage. Journal of Smooth Muscle Research, 41, 117–132. doi:10.1540/jsmr.41.117
   PubMedGoogle Scholar
• Tonini, M., Messori, E., Franceschetti, G. P., Rizzi, C. A., Castoldi, A. F., Coccini, T., & Candura, M. (1994). Characterization of the 5-HT receptor potentiating neuromuscular cholinergic transmission in strips of human isolated detrusor muscle. British Journal of Pharmacology, 113, 1–2. doi:10.1111/bph.1994.113.issue-1
   PubMed Web of Science ®Google Scholar
• Vernon, L. T., Fuller, M. A., Hattab, H., & Varnes, K. M. (2000). Olanzapine-induced urinary incontinence: Treatment with ephedrine. Journal of Clinical Psychiatry, 61, 601–602. doi:10.4088/JCP.v61n0810c
   PubMedGoogle Scholar
• Warner, J. P., Harvey, C. A., & Barnes, T. R. (1994). Clozapine and urinary incontinence. International Clinical Psychopharmacology, 9, 207–209. doi:10.1097/00004850-199409000-00010
   PubMed Web of Science ®Google Scholar